Very late-onset complete atrioventricular block following deployment of Amplatzer membranous ventricular septal defect occluder

RATIONALE: Although implantation of Amplatzer membranous ventricular septal defect occluder (AVSDO) is an alternation to surgical treatment, the interventional therapy is disapproved by FDA due to high incidence of complete atrioventricular block (cAVB) post closure during early and middle term foll...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, Shuran, Luo, Chunyan, Zhou, Kaiyu, Hua, Yimin, Wang, Chuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
6200
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6940049/
https://www.ncbi.nlm.nih.gov/pubmed/31861006
http://dx.doi.org/10.1097/MD.0000000000018412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6940049/
https://www.ncbi.nlm.nih.gov/pubmed/31861006
http://dx.doi.org/10.1097/MD.0000000000018412

Ejemplares similares